It’s time to leverage this powerful genomic technology to help improve lives. Learn how the PhosphorusONE test can help you take control of your genomic health.
The new genetic test targets over 20 genes associated with familial hypercholesterolemia (FH), hypobetalipoproteinemia, familial chylomicronemia, familial hypertriglyceridemia, and disorders of lipid metabolism.
The company's ophthalmologic tests can help guide vision loss management and complications from eye surgery. The pharmacogenomic test can help reduce the risk of adverse events from drugs.
The tests are designed to provide clarity on lifetime risk and drastically improve survival rates across cancer types.